Bipolar Transurethral Incision of Bladder Neck Stenoses with Mitomycin C Injection
Introduction. To determine the efficacy of bipolar transurethral incision with mitomycin C (MMC) injection for the treatment of refractory bladder neck stenosis (BNS). Materials and Methods. Patients who underwent bipolar transurethral incision of BNS (TUIBNS) with MMC injection at our institution f...
Saved in:
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2015-01-01
|
Series: | Advances in Urology |
Online Access: | http://dx.doi.org/10.1155/2015/758536 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832554228642480128 |
---|---|
author | Timothy D. Lyon Omar M. Ayyash Matthew C. Ferroni Kevin J. Rycyna Mang L. Chen |
author_facet | Timothy D. Lyon Omar M. Ayyash Matthew C. Ferroni Kevin J. Rycyna Mang L. Chen |
author_sort | Timothy D. Lyon |
collection | DOAJ |
description | Introduction. To determine the efficacy of bipolar transurethral incision with mitomycin C (MMC) injection for the treatment of refractory bladder neck stenosis (BNS). Materials and Methods. Patients who underwent bipolar transurethral incision of BNS (TUIBNS) with MMC injection at our institution from 2013 to 2014 were retrospectively reviewed. A total of 2 mg of 40% mitomycin C solution was injected in four quadrants of the treated BNS. Treatment failure was defined as the need for subsequent intervention. Results. Thirteen patients underwent 17 bipolar TUIBNS with MMC injection. Twelve (92%) patients had failed a mean of 2.2 ± 1.1 prior endoscopic procedures. Median follow-up was 16.5 months (IQR: 14–18.4 months). Initial success was 62%; five (38%) patients had a recurrence with a median time to recurrence of 7.3 months. Four patients underwent a repeat procedure, 2 (50%) of which failed. Overall success was achieved in 77% (10/13) of patients after a mean of 1.3 ± 0.5 procedures. BNS recurrence was not significantly associated with history of pelvic radiation (33% versus 43%, p=0.9). There were no serious adverse events. Conclusions. Bipolar TUIBNS with MMC injection was comparable in efficacy to previously reported techniques and did not result in any serious adverse events. |
format | Article |
id | doaj-art-819b1fb65b86469686ed744e0650accb |
institution | Kabale University |
issn | 1687-6369 1687-6377 |
language | English |
publishDate | 2015-01-01 |
publisher | Wiley |
record_format | Article |
series | Advances in Urology |
spelling | doaj-art-819b1fb65b86469686ed744e0650accb2025-02-03T05:52:06ZengWileyAdvances in Urology1687-63691687-63772015-01-01201510.1155/2015/758536758536Bipolar Transurethral Incision of Bladder Neck Stenoses with Mitomycin C InjectionTimothy D. Lyon0Omar M. Ayyash1Matthew C. Ferroni2Kevin J. Rycyna3Mang L. Chen4Department of Urology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USADepartment of Urology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USADepartment of Urology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USADepartment of Urology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USADepartment of Urology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USAIntroduction. To determine the efficacy of bipolar transurethral incision with mitomycin C (MMC) injection for the treatment of refractory bladder neck stenosis (BNS). Materials and Methods. Patients who underwent bipolar transurethral incision of BNS (TUIBNS) with MMC injection at our institution from 2013 to 2014 were retrospectively reviewed. A total of 2 mg of 40% mitomycin C solution was injected in four quadrants of the treated BNS. Treatment failure was defined as the need for subsequent intervention. Results. Thirteen patients underwent 17 bipolar TUIBNS with MMC injection. Twelve (92%) patients had failed a mean of 2.2 ± 1.1 prior endoscopic procedures. Median follow-up was 16.5 months (IQR: 14–18.4 months). Initial success was 62%; five (38%) patients had a recurrence with a median time to recurrence of 7.3 months. Four patients underwent a repeat procedure, 2 (50%) of which failed. Overall success was achieved in 77% (10/13) of patients after a mean of 1.3 ± 0.5 procedures. BNS recurrence was not significantly associated with history of pelvic radiation (33% versus 43%, p=0.9). There were no serious adverse events. Conclusions. Bipolar TUIBNS with MMC injection was comparable in efficacy to previously reported techniques and did not result in any serious adverse events.http://dx.doi.org/10.1155/2015/758536 |
spellingShingle | Timothy D. Lyon Omar M. Ayyash Matthew C. Ferroni Kevin J. Rycyna Mang L. Chen Bipolar Transurethral Incision of Bladder Neck Stenoses with Mitomycin C Injection Advances in Urology |
title | Bipolar Transurethral Incision of Bladder Neck Stenoses with Mitomycin C Injection |
title_full | Bipolar Transurethral Incision of Bladder Neck Stenoses with Mitomycin C Injection |
title_fullStr | Bipolar Transurethral Incision of Bladder Neck Stenoses with Mitomycin C Injection |
title_full_unstemmed | Bipolar Transurethral Incision of Bladder Neck Stenoses with Mitomycin C Injection |
title_short | Bipolar Transurethral Incision of Bladder Neck Stenoses with Mitomycin C Injection |
title_sort | bipolar transurethral incision of bladder neck stenoses with mitomycin c injection |
url | http://dx.doi.org/10.1155/2015/758536 |
work_keys_str_mv | AT timothydlyon bipolartransurethralincisionofbladderneckstenoseswithmitomycincinjection AT omarmayyash bipolartransurethralincisionofbladderneckstenoseswithmitomycincinjection AT matthewcferroni bipolartransurethralincisionofbladderneckstenoseswithmitomycincinjection AT kevinjrycyna bipolartransurethralincisionofbladderneckstenoseswithmitomycincinjection AT manglchen bipolartransurethralincisionofbladderneckstenoseswithmitomycincinjection |